Results 161 to 170 of about 61,625 (227)

Development of a Follow-Up Protocol for Patients Treated with Injectable Semaglutide for Weight Loss: Design of a Research Study in Community Pharmacy. [PDF]

Farm Comunitarios
Acuña Elvira N.
europepmc   +1 more source

[Rapid diagnosis of a case of post-surgical meningitis with BioFire® Joint Infection Panel]. [PDF]

Rev Esp Quimioter
Cuadrado García B, Madueño Alonso A, Martín Bermúdez A, Romero-Acevedo L, Pérez Orán P, Lecuona Fernández M.   +5 more
europepmc   +1 more source

[Annular Pancreas in Adults. A Case Report]. [PDF]

Acta Gastroenterol Latinoam
Marulanda Fernández H, Frías Ordoñez JS, Otero Regino W.   +2 more
europepmc   +1 more source

Geriatric cardiology. [PDF]

Arch Cardiol Mex
Lasses-Y-Ojeda LA.
europepmc   +1 more source

Avoidable hospitalizations for ambulatory care sensitive conditions in children under five years in Ecuador, 2000-2023. [PDF]

Cad Saude Publica
Buñay-Morocho C, Álvarez P, Zurita D, Martin M, Cooper P, Romero-Sandoval N, Gualán M.   +6 more
europepmc   +1 more source

[Small intestine bacterial overgrowth: Myths and realities]. [PDF]

Aten Primaria
Guardiola-Arévalo A, Mascort Roca J, Noguerol Álvarez M, Carrillo Muñoz R, Mendive Arbeloa JM, Amador Romero J.   +5 more
europepmc   +1 more source

[Cardiovascular manifestations in pediatric multisystem inflammatory syndrome associated with COVID-19 in a tertiary care pediatric center in Mexico City]. [PDF]

Arch Cardiol Mex
Granda-Jiménez MJ, Rios-Olivares IE, González-Rebeles-Guerrero C, Marquez-Aguirre MP, Gutiérrez-Hernández JA, Camacho-Reyes L, De Rubens-Figueroa J, Corona-Villalobos CA.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gastrointestinale Tumoren

Onkologische Welt, 2022
Next-Generation-Sequencing (NGS) oder Panels in Gewebe bzw. Liquid-Biopsie (ctDNA) – Biomarker können bei gastrointestinalen Tumoren (GI-Tumoren) therapieentscheidend sein. Dr. Pashtoon M. Kasi, New York, referierte auf einem Webinar über den aktuellen Stand der Basis-Biomarker und -Testungen.
openaire   +1 more source

Gastrointestinale Refluxkrankheit

Onkologische Welt, 2018
Rund 10–20 % der Erwachsenen sind in der westlichen Welt von einer gastrointestinalen Refluxerkrankung (GERD) betroffen, welche das Risiko für ösophageale Adenokarzinome steigert. Ob die medikamentöse Behandlung und operative Eingriffe dem vorbeugen, wird kontrovers diskutiert.
openaire   +1 more source